Lucence at #NACLC22

Dare to Compare
September 23-25, 2022

From the CEO

Friends and colleagues,

Please join us at the North America Conference on Lung Cancer (NACLC) in Chicago from September 23-25 2022.

I’m very excited that early results of LiquidHALLMARK’s prospective, multicenter comparison study will be shared at the conference. Our team will be present and I certainly hope you will get in touch!

For questions or assistance, do not hesitate to reach out to us . I’m looking forward to seeing you in person!


Min Han Tan

news-image1 news-image2


Lucence showcases promising comparison study results from LIQUIK, a prospective, multi-center liquid biopsy study for mNSCLC, at the 2022 North America Conference on Lung Cancer.

Poster Presentations
and Abstracts for #NACLC22

25 September 2022


Richa Dawar1, Jennifer Carney2, Robert M Jotte3, James Orsini Jr.4, Katherine Scilla5, Gilberto Lopes1, Min-Han Tan6, Boon Cher Goh7, Yew Oo Tan8, Tan Min Chin9, Chee Keong Toh10, Jens Samol11,12.


1University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, USA; 2Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, USA; 3Rocky Mountain Cancer Centers, Denver, Colorado, USA; 4New Jersey Cancer Care, Belleville, New Jersey, USA; 5University of Maryland School of Medicine, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; 6Lucence Health, Palo Alto, California, USA; 7National University Hospital, Singapore; 8Icon Cancer Centre Farrer Park, Singapore; 9Parkway Cancer Centre, Singapore; 10Curie Oncology, Singapore; 11Medical Oncology Tan Tock Seng Hospital, Singapore; 12Johns Hopkins University, Baltimore, USA

Abstract 103

Poster number: PP01.74

Get Updates

Sign up for the latest news and updates about Lucence at #NACLC22. For questions, email us at [email protected].